Loading
Latest filing published 26 Aug 2024 for Agile Therapeutics INC, €18.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Josephine Torrente is a declared insider of Agile Therapeutics Inc (board member), with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 7 October 2021 to 26 August 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 26 August 2024, reports a transaction of €1,326 in Agile Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations